EPIGRAL

Jan 27 (Reuters) - Epigral Ltd EPIG.NS:

• EPIGRAL DEC-QUARTER CONSOL NET PROFIT 1.04 BILLION RUPEES

• EPIGRAL DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 6.45 BILLION RUPEES

• EPIGRAL LTD - DIVIDEND 2.5 RUPEESPER SHARE

Source text: [ID:]

Further company coverage: EPIG.NS

(([email protected];))

Aug 14 (Reuters) - Epigral Ltd EPIG.NS:

• EPIGRAL LTD - TO RAISE FUNDS WORTH UP TO 5 BILLION RUPEES

Source text for Eikon: ID:nNSE6lFb83

Further company coverage: EPIG.NS

(([email protected];))

** Shares of Epigral Ltd EPIG.NS rise 10% to their highest levels since Oct 2022

** The chemicals manufacturer posted a 172% y/y rise in consolidated net profit, rev rose 43%

** Stock on track to rise for a third straight day, gaining around 15% in these sessions

** Trading vols at 5x the 30-day avg, stock sees busiest day in nearly four months

** EPIG stock up 66% YTD; it dropped about 22% in 2023

(Reporitng by Nishit Navin)

(([email protected];))

April 22 (Reuters) - Epigral Ltd EPIG.NS:

• DIVIDEND 5 RUPEES PER SHARE

• MARCH-QUARTER CONSOL NET PROFIT 772.8 MILLION RUPEES VERSUS 767.3 MILLION RUPEES

• MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 5.25 BILLION RUPEES VERSUS 5.62 BILLION RUPEES

Source text for Eikon: ID:nNSE53Hpwy

Further company coverage: EPIG.NS

(([email protected];))

April 3 (Reuters) - Epigral Ltd EPIG.NS:

• COMMISSIONED AN ADDITIONAL 45,000 TPA CAPACITY OF CPVC RESIN PLANT AT ITS DAHEJ FACILITY

• AFTER EXPANSION, CO'S TOTAL CPVC RESIN CAPACITY REACHES 75,000 TPA

• EPIGRAL IS ALSO VENTURING INTO CPVC COMPOUND PRODUCTION, WITH A PROJECTED CAPACITY OF 35,000 TPA

• EXPANSION PROJECT IS UNDER PROGRESS AND IS EXPECTED TO BE COMMISSIONED IN Q1 OF FINANCIAL YEAR 2025

Source text for Eikon: ID:nBSEbSj9Mc

Further company coverage: EPIG.NS

(([email protected];))

Jan 24 (Reuters) - Epigral Ltd EPIG.NS:

• EPIGRAL LTD DEC-QUARTER CONSOL NET PROFIT 490.8 MILLION RUPEES VERSUS 772 MILLION RUPEES

• EPIGRAL LTD DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 4.72 BILLION RUPEES VERSUS 5.38 BILLION RUPEES

Source text for Eikon: ID:nNSEbr3GfZ

Further company coverage: EPIG.NS

(([email protected];))

Nov 6 (Reuters) - Epigral Ltd EPIG.NS:

• EPIGRAL LTD SEPT-QUARTER CONSOL NET PROFIT 380 MILLION RUPEES VERSUS 915.7 MILLION RUPEES

• EPIGRAL LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.78 BILLION RUPEES VERSUS 5.56 BILLION RUPEES

(([email protected];))

By Savio Shetty

Sept 21 (Reuters) - Indian chemicals maker Epigral EPIG.NS will keep diversifying its business and expects the share of revenue from new products to expand significantly this year, its chairman and managing director told Reuters on Thursday.

The company, previously known as Meghmani Finechem, manufactures and sells chlor-alkali and its derivatives and set up a chlorinated polyvinyl chloride compound (CPVC) manufacturing facility last month in the state of Gujarat.

"Four years ago, we were (present) only in chlor-alkali. At that time, we were catering to seven industries," Maulik Patel told the Reuters Trading India forum.

The company now caters to more than 15 industries after entering segments like chloromethanes (CMS), hydrogen peroxide, chlorinated polyvinyl chloride (CPVC) and epichlorohydrin, Patel said.

Epigral is the largest producer of CPVC and the first to produce epichlorohydrinin in India, with its products being used as raw materials in industries ranging from pharmaceuticals to pipes.

The specialty chemicals market represents 22% of India's overall chemicals and petrochemicals market and is valued at $32 billion, according to KPMG.

Patel sees the Ahmedabad-headquartered company increasing its share of derivative products over the current and next financial year.

"As of fiscal year 2023, derivative and specialty segment contributed 30% of 21.84 billion rupee ($263 million) revenue, and by the end of this financial year it should reach 45% or 50%."

Epigral plans to triple its exports, which currently contribute to 4% of sales, over the next two years, Patel said. It exports its products to more than 20 countries including South Africa and the United States.

"Few of our products have good demand in global markets, like Epichlorohydrin. We will also have an export opportunity once we commission our Chlorotoluene plant. Exports could rise between 10% to 15% over the next couple of years," he added.

(Join Trading India, a chat room hosted on Refinitiv Messenger: https://bit.ly/3TNDwkC)

($1 = 83.0434 Indian rupees)

(Reporting by Savio Shetty; Editing by Sonia Cheema)

(([email protected];))

Aug 31 (Reuters) - Epigral Ltd MEGM.NS:

• VENTURING TO SET-UP CHLORINATED POLYVINYL CHLORIDE COMPOUND MANUFACTURING FACILITY

• CPVC COMPOUND MANUFACTURING FACILITY OF 35000 TPA CAPACITY

• ADDITIONAL CAPEX OF 250 MILLION RUPEES WHICH IS EXPECTED TO BE COMMISSIONED BY Q4FY24

• SAID EXPANSION PLAN IS IN SYNERGY WITH CO'S CPVC RESINS

Source text for Eikon: ID:nNSEbvxPRX

Further company coverage: MEGM.NS

(([email protected];;))

** Shares of Meghmani Finechem Ltd MEGM.NS fall as much as 5.3% to 993.3 rupees, biggest intraday pct. loss since March 15

** Essential chemicals maker says March-qtr consol. net profit dropped 23% to 767.3 mln rupees ($9.4 mln) hurt by soaring input costs

** Co's consol. revenue from operations rose 13% to 5.62 bln rupees

** Stock trading below its 100-, and 200-day moving averages

** Trading volume at ~130,000 shares, 2x the 30-day avg as of 1:35 p.m. IST

** Up to last close, stock was down ~16% so far this year

($1 = 81.9230 Indian rupees)

(Reporting by Biplob Kumar Das in Bengaluru)

(([email protected]))